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Functional endoscopic sinus surgery is the preferred 
treatment for chronic rhinosinusitis currently. Success on 
symptoms relief and quality of life improvement are the 
study leading objectives. Study design: retrospective 
clinical trial. Methods: Questionnaires were given to the 
patients referred to Hospital das Clinicas-UFPE to chronic 
rhinosinusitis (CRS) functional endoscopic sinus intervention 
during 2003-2004. Symptoms outcome before and after 
surgery were compared and analyzed using a five-point-
ranking scale. Results: Twenty-four pacients answered 
the questions. Eleven pacientes had CRS and 13 had CRS 
associated with nasal polypos. Quality of life was restricted by 
CRS in everyone, with a good improvement in 54,2% cases. 
All patients could recommend functional endoscopic sinus 
surgery to someone with same nasal problems and only 3 
would not get surgery again. The best symptoms relif results 
were: nasal obstruction (83,3%), cacosmia/halitosis (80%), 
hyposmia/anosmia (63,15%), headache (62%). Patients with 
polyps achieved better symptomatic response than patients 
with only CRS. Conclusions: The leading simptoms were 
improved by functional endoscopic sinus surgery but not so 
much we expect. Allergic rhinits presenting, not using nasal 
spray, poor ambient control influenced this result. Polyps 
patient achivied better symptoms outcome and quality of life 
responses on the most of symptoms than CRS pacients.
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INTRODUCTION
Currently, endoscopic sinus surgery is seen as 
the standard treatment in clinically challenging chronic 
rhinosinusitis (CRS) and in nasosinusal polyposis. The en-
doscopic procedure is based on the principles introduced 
by Messerklinger1 , which prioritize both the function and 
the permeability of pre-ethmoidal spaces, in a precise and 
guided intervention on the lateral wall of the nose, thus 
bringing about good ventilation and drainage for facial 
sinuses. In 1985, Kennedy2 described this technique and 
popularized the term “Functional Endoscopic Sinus Sur-
gery - FESS”. Since then, there have been a number of 
progresses in both the technique and surgery indication.
There are a number of papers in the literature 
about the efficacy of the endoscopic surgery, reports of 
its capabilities and questions about its true worth3,4. Not-
withstanding, in order to assess how efficient a treatment 
method is, we have, first of all, to define the pathology 
for which the treatment will be used. In our study we as-
sessed FESS efficiency in mitigating, or even abolishing 
symptoms related to CRS alone or associated with nasosi-
nusal polyposis, through a questionnaire bearing simple 
questions and direct answers on the severity of symptoms 
presented by such patients. 
METHODOLOGY
Our study encompassed 24 patients who answered 
the questionnaire proposed and underwent FEES in the 
years of 2003 and 2004. Of this total, 11 were diagnosed 
with CRS and 13 with CRS associated with nasosinusal 
polyposis. We excluded recurrences and reoperation 
cases. The diagnosis of both pathologies was clinical and 
radiological; and the clinical treatment attempted for CRS 
was based on large spectrum antibiotics against upper 
airway infections and topical steroids, as nasal sprays, for 
at least twelve weeks. 
All the endoscopic procedures were carried out in 
the University Hospital of the Federal University of Per-
nambuco, under general anesthesia, by second and third 
year residents under supervision. According to the protocol 
in our service, the surgical technique used was the one 
described by Messerklinger1 and Stammberger5. Average 
hospital stay was 24 hours, with post-operative follow up 
in 7, 15, 30 days, and in 6 months. Cephalexin was used 
for 7 days in the post-op, and the patients were instructed 
to vigorously spray 0.9% saline solution in their noses. 
Topical steroid was started 15 days after the procedure, and 
continued if necessary. Patients with nasosinusal polyps 
also used Betamethasone for 10 days prior to surgery and 
20mg/day of prednisolone for 7 days after the procedure. 
Nasal cleaning and crust removal were carried out in the 
post op follow up.
All these patients answered questionnaires about 
their symptoms and their life quality before and after sur-
gery (Attachment 1). 12 questions were prepared about 
pre-op symptoms and 15 about post-op symptoms. We 
Questionnaire
Name:
Data of surgery:
Indication: (  ) polyps (  ) chronic sinusitis
1 - How does the disease affect your life quality?
( ) Does not affect ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
2 - How much does the disease obstruct your nose?
( ) Does not obstruct ( ) a little ( ) somewhat ( ) much ( ) inca-
pacitates
3 - How about headaches?
( ) Does not have ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
4 -How about olfaction?
( ) Does not affect ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
5 - How about secretion?
( ) Does not affect ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
6 - How about dry nose or dry mouth?
( ) Does not have ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
7 - How about cough?
( ) Does not have ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
8 - How about asthma?
( ) Does not have ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
9 - How about post nasal discharge?
( ) Does not have ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
10- How about foul smell or bad breath?
( ) Does not have ( ) a little ( ) somewhat ( ) much ( ) incapaci-
tates
The following questions are only for patients who have already 
been operated:
11- If your disease returned, would you operate again?
( ) Yes   ( ) no
12- Would you recommend this procedure to another person?
( ) Yes   ( ) no
Attachment 1.
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were careful enough to use simple language in preparing 
the questions so that all the patients would understand 
them. Each answer was scored from 0 to 5 according to 
Likert’s scale6, as depicted in the attached questionnaire. 
The questionnaire was adapted from the literature7 and 
the information generated compared CRS alone and CRS 
with polyps patients. 
In order to analyze the data, we considered good 
surgery outcome when the score difference between pre 
and post operative symptoms for each variable resulted 
in a positive value equal or above 2. If the difference 
resulted in a negative value, equal or above 2, the proce-
dure was considered a failure. In cases which the score 
difference between pre and post op were between +1 or 
-1, we concluded that the procedure did not influence a 
certain symptom. 
All patients signed an informed consent approved 
by the Hospital Ethics Committee and were duly explained 
about the study goals, and their personal information was 
not disclosed. 
RESULTS
Of all the patients who answered the questionnaire, 
10 were male and 14 were female, all young adults. They 
were then separated in two groups, the ones of CRS alone 
were 11 in total and those with CRS and polyps were 13. As 
for health improvement after the procedure, in both groups 
50% reported excellent outcome. Life quality was impaired 
in all interviewed patients, and it improved considerably in 
54.2% of the cases. All those interviewed patients would 
recommend the procedure to other people with similar 
nasosinusal problems and only 3 patients would not un-
dergo the surgery again if the problem recurred.
Table 1 lists the symptoms reported by patients with 
CRS and CRS with nasosinusal polyps. Table 2 depicts the 
results obtained through FESS surgical success criteria 
described in the methodology.
The most prevalent symptoms were: nasal obstruc-
tion, headaches (present in all patients with CRS), secre-
tion and dry throat (present in all patients with CRS and 
polyps). We compared symptoms improvement in both 
CRS and CRS with nasal polyps. Hyposmia was present in 
7 patients with CRS, with improvement in 4 cases (57.1%). 
In CRS and polyps we had improvement in 8 of the 12 
patients (66.6%).
Graph 1 compares most prevalent symptoms im-
provement in CRS and CRS with polyps. 
DISCUSSION
Chronic rhinosinusitis is one of the most common 
diseases in the United States. It is estimated that 15% of 
the American population has CRS8. This pathology is based 
on the chronic inflammation of the paranasal sinuses 
Table 1. Symptoms prevalence found in patients who underwent 
functional endoscopic sinus surgery to treat chronic rhinosinusitis 
and nasal polyps.
Symptom CRS CRS and Polyps
Nasal obstruction 11 (100%)* 13 (100%)
Headaches 11 (100%) 10 (77%)
Hyposmia/anosmia 7 (63,5%) 12 (92,3%)
Secretion 9 (82%) 13 (100%)
Dry throat 5 (45,5%) 13 (100%)
Cough 4 (36,3%) 9 (69,2%)
Asthma 3 (27,2%) 5 (38,5%)
Post-nasal drip 8 (72,7%) 11 (84,6%)
Cacosmia and halitosis 6 (54,5%) 4 (30,7%)
*The percentage was calculated based on the total number of patients 
with CRS in the first column and the total number of patients with CRS 
and polyps in the second column.
Table 2. General success rates achieved in treating symptoms with 
FESS reported by the patients.
Improved* No 
change*
Got 
worse
Without the 
symptom
Nasal obstruc-
tion
20 (83,3%) 4 (16,7%) 0 0
Headaches 13 (61,9%) 8 (38,1%) 0 3
Hyposmia/anos-
mia
12 (63,9%) 7 (36,1%) 1 4
Secretion 10 (45,4%) 12 (55,6%) 0 2
Dry throat 10 (55,5%) 8 (44,5%) 0 6
Cough 4 (30,7%) 9 (69,3%) 1 10
Asthma 2 (25,0%) 6 (75,0%) 0 16
Post-nasal drip 9 (47,3%) 10 (52,7%) 0 5
Cacosmia and 
halitosis
8 (80%) 2 (20%) 0 14
*The percentage was calculated based on the total number of patients 
who presented each specific symptom.
Graph 1.
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mucosa, with secretion stasis and bacterial infection. The 
Brazilian consensus has defined it as an inflammatory 
process in the mucosa that lines the nasal cavity and 
paranasal sinuses, with symptoms remaining for over 12 
weeks. CRS symptoms may range from minor to major. 
The major symptoms are nasal obstruction, a feeling of 
facial pressure, rhinorrhea and hyposmia; and the minor 
symptoms are: headache, toothache, halitosis, fatigue, dry 
cough, fever and earache9, whereas 2 major symptoms, 
one major and 2 minors or purulent discharge in the nasal 
cavity suggest CRS. 
Nasosinusal polyps are the most frequent indica-
tion for nasosinusal endoscopic surgical intervention, after 
CRS. The cause of polyp formation is still uncertain. There 
are theories based on edematous alterations in the nasal 
mucosa, and others that advocate the participation of fungi 
in the physiopathology of this disease. The nasal polyp 
may be single, clearly outlined or involving all the facial 
sinuses, being thus characterized as nasosinusal polyposis 
or diffuse polyposis. The staging proposed by Stamm is 
based on four levels of disease10. The most frequent sites 
for polyps are the anterior spaces of the ethmoid sinus 
where the symptoms reported by patients are very much 
similar to those reported by CRS patients - nasal obstruc-
tion is the major complaint11.
Both CRS and nasal polyps diagnosis are based on 
clinical criteria. The purely subjective symptoms, described 
by the patients, should guide the medical treatment, as far 
as for complementary tests to be ordered - CT scan is the 
foremost, therapeutic to be used. Thus, any study dedi-
cated to measure the efficacy of nasal endoscopic surgery 
for these pathologies should be based on symptoms. The 
patients’ complaints and how much the disease is limiting 
their daily activities should be the focus of such analysis. In 
our department, those patients who fulfill the clinical crite-
ria for CRS are referred to surgery, always with paranasal 
sinuses CT scan, as are those who have failed the clinical 
treatment for the disease. Patients with nasal polyposis 
above level II are also always referred to surgery. 
It is hard to measure health and life quality issues. 
According to the World Health Organization, it encom-
passes physical, social and mental well being. On the other 
hand, social well being may change according to a country 
culture and development level. As we attempt to assess 
how much the disease impairs a patient’s life quality, we 
adapted the questionnaire for our population. By doing so, 
we have facilitated the very dialogue between interviewer 
and interviewee, besides obtaining a social assessment 
compatible with the environment where they live. 
Two interesting studies were carried out using 
questionnaires to assess the life quality of patients with 
CRS. Damm’s7 study found post operative improvement 
in 85% of the cases, and Bhattacharyya’s6 study stressed 
the improvement of most symptoms in all patients, with 
greater emphasis in facial pain, congestion, nasal obstruc-
tion, rhinorrhea and headache. 
In our study, we found general health improvements 
in 50% of the patients; and 54.2% of them said they enjoyed 
considerable gain in life quality. Notwithstanding, all the 
patients interviewed would recommend this procedure to 
a friend or relative, while only 3 would not undergo the 
surgery again if the problem recurred. When compared to 
the literature, we considered the life quality gain to be low. 
This may be due to the fact that chronic nasosinusal inflam-
matory diseases are frequently associated to a number of 
factors such as immune deficiencies, muco-ciliary altera-
tions, vasomotor hyperactivity and atopy, which would 
definitely influence clinical outcome and surgical result. 
Alergic rhinitis was a problem reported by many of the 
interviewees, and it was known by all that such problem 
is not surgically treatable; its control should be carried out 
after surgery. At this point it is worth highlighting those low 
income patients often times do not follow post-operative 
prescriptions for anti-histamine and topical steroids. We 
must also bear in mind the environmental conditions where 
they live, with very little environmental control.
AS reported by other authors6,7,12, nasal obstruction, 
rhinorrhea and headache are the CRS symptoms that most 
impact life quality. In our study, these were also frequent 
complaints, especially when there were polyps associated. 
Nasal obstruction was present in 100% of the patients, 
headaches in 87.5% and rhinorrhea in 91.6%. Another very 
common symptom in our series, and not often reported in 
other papers, was hyposmia, which reached 83.3% of the 
patients. In approximately 36% of the patients, polyps may 
come from the olfactory mucosa, causing hyposmia, in our 
study; only one patient did not have any smell alteration. 
All other patients who complained of olfactory reduction 
had polyps, not only in the nasal roof, but in the entire 
nasal cavity, and the origin for hyposmia was both air flow 
obstruction and olfactory mucosa alteration.
Patients with nasosinusal polyps presented a certain 
trend toward more exuberant symptoms than those with 
CRS alone. All nasal polyp patients reported headaches, 
nasal obstruction, rhinorrhea and dry throat, and over 80% 
of them complained of smell alterations and post nasal 
drip. Such results should be analyzed considering that the 
study was carried out in a tertiary public hospital, where 
the difficult access to health services may delay diagnosis 
and to where the most severe cases are referred.
In Dursun’s13 study, where they tried to determine 
FESS success in CRS, polyps had 73.6% of post operative 
improvement, while recurrent polyposis had a 23.8% suc-
cess rate. In general, FESS subjective success in treating 
CRS was reached in 83% of the cases, with 54.4% of the 
cases presenting associated nasosinusal polyposis. 
In our study, symptoms that had the most improve-
ment after surgery were nasal obstruction, headache and 
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hyposmia. Polyp patients had a trend of presenting with 
greater symptoms relief after surgery. Nasal obstruction 
was present in both groups of patients, with a 92% im-
provement in patients with polyps (only one did not get 
better), and 72.7% in those with chronic nasosinusitis 
alone. Of the 10 patients with polyps who complained 
of headaches, seven improved, while in the 11 patients 
belonging to the CRS group only 6 improved. In CRS, 
there was a 20% improvement in dry throat, with only one 
patient reporting improvement among the five of them 
who had the symptom. In patients with nasal polyps, there 
was a 69.2% improvement rate, because 13 had dryness 
and nine improved. It is interesting to notice that besides 
the symptoms questioned, some patients with polyps re-
vealed the stigma of a “growing meat leaving their nose”, 
which prevented them from leaving their homes because 
of prejudice. The improvement in these patients’ low self 
esteem make them report a greater surgical success than 
those with CRS alone, and it seems to us that the life quality 
improvement in cases of nasosinusal polyps goes beyond 
common symptoms improvement.
We highlight the fact that our study was carried out 
in a Public Hospital, where patients are somewhat used 
to long standing suffering of diverse origins and are not 
very demanding, and this makes it difficult to compare 
our data with those reported in the literature, which usu-
ally come from developed countries in different settings14. 
Other studies carried out in our country are necessary in 
order to assess the impact of surgical interventions on the 
life quality of our patients. 
Our analysis tool did not offer us an objective mea-
sure of FESS efficacy, notwithstanding, our goal was to 
clarify whether or not there were clinical improvements 
in certain symptoms from each patient. We have sought 
subjective improvement, aware that this may not cor-
respond to a “radiological” cure, but rather the patient’s 
satisfaction toward the surgical approach. 
CONCLUSIONS
Symptoms improvement attained with the endo-
scopic procedure has been satisfactory; however, the 
improvement magnitude was lower than what had been 
expected. The best results were achieved with nasal per-
meability and halitosis and cacosmia improvement after 
surgery. The low surgical improvement of some symptoms, 
such as rhinorrhea, may have been influenced, in our set-
tings, by the presence of allergic rhinitis in patients with 
poor environmental control and the lack of nasal spray 
use. It is interesting to notice that those with nasal polyps 
reported more complaints in the pre-op and reported 
greater improvement in life quality, for most of the symp-
toms, when compared to CRS patients. 
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